63 Real-world outcomes of Nivlolumab-Ipilimumab combination therapy in unresectable malignant mesothelioma: Mount Vernon Cancer Centre Experience

We report real-world toxicity and outcomes from several hospitals within our Trust.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Tabitha Achim, Mujtaba Ehsan, Karen Henderson, Thalia Afxentiou, Vikash Dodhia, Wendy Ng, Ridwan Ahmed, Andreas Polychronis, Geirgios Antoniou, Ernese Xhafa-Hamati, Arshi Denton, Suzannah Mawdsley, Jeanette Dickson, Suprotim Basu, Suraiya Dubash Tags: Mesothelioma Source Type: research